One in 10 people may resist GLP-1 diabetes drugs
New research suggests that certain genetic variants can decrease the ability of GLP-1 diabetes drugs to regulate blood sugar – a mysterious phenomenon known as GLP-1 resistance.
Clinical care, research, and education fuel innovation to advance human health.
We coordinate expertise with the most advanced treatments and technology for the best possible patient outcomes.
Stanford Medicine delivers unparalleled care for each patient’s unique needs. Our multidisciplinary approach to health care coordinates expertise with the most advanced technology for the best possible outcomes.
Stanford Children’s Health is the only health care network in the Bay Area – and one of the few in the country – exclusively dedicated to pediatric and obstetric care.
We are drawn to the difficult problems, the ones for which prevailing science does not yet have a framework to understand.
New research suggests that certain genetic variants can decrease the ability of GLP-1 diabetes drugs to regulate blood sugar – a mysterious phenomenon known as GLP-1 resistance.
Stanford researchers are using drones and artificial intelligence to hunt down hidden mosquito breeding sites as warming temperatures spread dengue to new regions.
Two-thirds of Americans living with Alzheimer’s disease today are women. Stanford Medicine neurologists explain what is known — and still unknown — about the factors behind that gap.
Our strength in interdisciplinary scholarship, our dedicated faculty, and a culture of innovation set the training ground for the next generation of biomedical leaders and pioneers.
With easy access to world-class faculty and coursework in medical science as well as engineering, computer science, education, business, and the humanities, aspiring physicians and scientists can experiment across disciplines and customize their education to match their interests.